TABLE 2

Results of Static and Kinetic 18F-FET PET Parameter of Patients With and Without Malignant Progression

BaselineMalignant progression/suspected malignant progression
Patient no.Histology of LGG (WHO grade II)TBRmaxTBRmeanTTP (min)Kinetic patternHistology after MP/suspected MPTBRmaxTBRmeanTTP (min)Kinetic pattern
Patients with MP
 1A1.30.9451AA3.62.2302
 2A1.41.1351AOA3.82.4252
 3A3.11.9302AOA6.42.9133
 4A3.32.0401AA4.72.3252
 5A1.21.0172GBM3.52.5113
 6A1.71.2401AA4.72.2253
 7A2.91.9451AA4.72.5302
 8OA1.81.1401AOA2.51.8202
 9A1.61.0452AA3.82.5252
 10E3.52.2203E (grade III)3.52.153
 11ODG2.51.8202AODG2.82.0202
 12A2.31.8451AA4.32.383
 13ODG5.12.8133GBM5.32.4133
 14A1.50.9351AA2.81.8252
 15A2.01.6132GBM3.22.2173
 16A2.61.9202AA2.31.6302
 17A1.61.2451GBM3.11.9173
 18A3.32.6351AOA3.62.8302
Patients without MP
 19OA4.12.3252OA4.51.9252
 20A1.91.6302OA1.81.1451
 21OA4.52.4133OA3.92.3133
 22A3.42.3351A2.11.8172
 23OA5.22.6302OA4.62.6252
 24A1.51.1451A1.91.7451
 25A4.22.6173A4.72.9133
 26OA3.12.0352OA4.52.9352
 27A3.41.9301A2.41.9401
  • MP = malignant progression; A = astrocytoma; AA = anaplastic astrocytoma; AOA = anaplastic oligoastrocytoma; GBM = glioblastoma; OA = oligoastrocytoma; E = ependymoma; ODG = oligodendroglioma; AODG = anaplastic oligodendroglioma.